EBR:TUB - Euronext Brussels - BE0003823409 - Common Stock - Currency: EUR
EBR:TUB (3/7/2025, 7:00:00 PM)
145.2
-1.4 (-0.95%)
The current stock price of TUB.BR is 145.2 EUR. In the past month the price decreased by -4.97%. In the past year, price increased by 64.25%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1LLY.MI | ELI LILLY & CO | 67 | 760.43B | ||
LLY.DE | ELI LILLY & CO | 66.98 | 760.15B | ||
ZEG.DE | ASTRAZENECA PLC | 21.82 | 446.45B | ||
JNJ.DE | JOHNSON & JOHNSON | 16.81 | 372.31B | ||
1JNJ.MI | JOHNSON & JOHNSON | 16.61 | 367.98B | ||
NOV.DE | NOVO NORDISK A/S-B | 26.21 | 355.97B | ||
SNW.DE | SANOFI | 14.32 | 275.64B | ||
SAN.PA | SANOFI | 14.27 | 274.84B | ||
1SAN.MI | SANOFI | 14.19 | 273.18B | ||
6MK.DE | MERCK & CO. INC. | 12.64 | 224.82B | ||
1MRKX.MI | MERCK & CO. INC. | 12.47 | 221.79B | ||
PFE.DE | PFIZER INC | 8.69 | 140.81B |
Financiere de Tubize SA is a holding company, which engages in investing in the biopharmaceuticals industry. The company is headquartered in Brussels, Bruxelles-Capitale. The firm holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The firm promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.
FINANCIERE DE TUBIZE
Allee de la Recherche, 60
Brussels BRUXELLES-CAPITALE BE
Employees: 3
Company Website: http://www.financiere-tubize.be/
Investor Relations: http://www.financiere-tubize.be/index.php?lang=en&page=rapport_annuel
Phone: 320497515208
The current stock price of TUB.BR is 145.2 EUR. The price decreased by -0.95% in the last trading session.
The exchange symbol of FINANCIERE DE TUBIZE is TUB and it is listed on the Euronext Brussels exchange.
TUB.BR stock is listed on the Euronext Brussels exchange.
6 analysts have analysed TUB.BR and the average price target is 178.5 EUR. This implies a price increase of 22.93% is expected in the next year compared to the current price of 145.2. Check the FINANCIERE DE TUBIZE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
FINANCIERE DE TUBIZE (TUB.BR) has a market capitalization of 6.46B EUR. This makes TUB.BR a Mid Cap stock.
FINANCIERE DE TUBIZE (TUB.BR) currently has 3 employees.
FINANCIERE DE TUBIZE (TUB.BR) has a support level at 144.78 and a resistance level at 145.92. Check the full technical report for a detailed analysis of TUB.BR support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FINANCIERE DE TUBIZE (TUB.BR) has a dividend yield of 0.46%. The yearly dividend amount is currently 0.73. Check the full fundamental report for a detailed analysis of TUB.BR dividend history, reliability and sustainability.
FINANCIERE DE TUBIZE (TUB.BR) will report earnings on 2025-03-22.
ChartMill assigns a technical rating of 8 / 10 to TUB.BR. When comparing the yearly performance of all stocks, TUB.BR is one of the better performing stocks in the market, outperforming 95.44% of all stocks.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to TUB.BR. The Buy consensus is the average rating of analysts ratings from 6 analysts.